abstract |
The present invention relates to the use of (R) -3, which is useful in the treatment of diseases associated with the activity of Janus kinase, which modulates the activity of Janus kinase and which is, for example, an immune related disease, skin disorder, myeloproliferative disorder, cancer, - (4- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -1H-pyrazol-1-yl) -3-cyclopentylpropanenitrile. |